Knoxville, TN 的 轉移性癌症 臨床試驗
7 項針對 轉移性癌症 的研究正在 Knoxville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
招募中2/3 期
- University of Tennessee Medical Center, Knoxville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Tennessee Cancer Specialists Dowell Springs location, Knoxville
- University of Tennessee Medical Center, Knoxville
- Tennessee Cancer Specialists - Parkwest Location, Knoxville
CREO - Microwave Ablation Feasibility Study
招募中
- University of Tennessee Medical, Knoxville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- University of Tennessee Medical Center, Knoxville
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
招募中2 期
- University of Tennessee Medical Center, Knoxville
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
招募中3 期
- Research Site, Knoxville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- University of Tennessee Medical Center, Knoxville
其他城市的 轉移性癌症 試驗
- Houston, TX104 項研究
- New York City, NY93 項研究
- Nashville, TN70 項研究
- Boston, MA63 項研究
- Los Angeles, CA57 項研究
- St. Louis, MO54 項研究
- Arlington, VA53 項研究
- Philadelphia, PA46 項研究
- Chicago, IL45 項研究
- San Antonio, TX44 項研究
- Washington, DC43 項研究
- Dallas, TX42 項研究
Knoxville 的其他研究
- 非小細胞肺癌14 項研究
- 肥胖症10 項研究
- 肺癌10 項研究
- 乳癌9 項研究
- 癌症（所有類型）8 項研究
- 過重7 項研究
- 心臟衰竭7 項研究
- 心血管疾病6 項研究
- 黑色素瘤5 項研究
- 第二型糖尿病5 項研究
- 高血壓5 項研究
- 慢性阻塞性肺病5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。